Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2010
09/21/2010US7799331 formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent; endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, respiratory diseases, hemaologic disorders, neoplastic diseases, edema, gastrointestinal disease
09/21/2010US7799318 Free of dimethicone; blending propylene glycol and dibenzylidene sorbitol, antiperspirant active solid powder, and adding amino acid salt to antiperspirant blend for stabilizing the dibenzylidene sorbitol
09/21/2010US7799016 Magnetic breather pump and a method for treating a brain tumor using the same
09/21/2010US7798475 Device, method and use for the formation of small particles
09/21/2010CA2569549C Heat sterilization of glucocorticosteroids
09/21/2010CA2556185C A microemulsion preparation of high concentration propofol for anesthetic uses
09/21/2010CA2466770C Liquid pharmaceutical formulations of acetaminophen and an alkali metal 1-lactate salt
09/21/2010CA2451915C Crystalline composition containing escitalopram
09/21/2010CA2449521C Pharmaceutical formulation, its use, and method for its manufacture
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2437150C Ph-sensitive mucoadhesive film-forming gels and wax-film composites
09/21/2010CA2433280C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
09/21/2010CA2396045C Aqueous ionic solutions and their uses in particular in ophthalmology
09/21/2010CA2393603C Microchip devices for delivery of molecules and methods of fabrication thereof
09/21/2010CA2376916C Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
09/21/2010CA2365890C Method for delivering benzindene prostaglandins by inhalation
09/21/2010CA2361081C Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
09/21/2010CA2345659C Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2338073C Novel urokinase inhibitors
09/21/2010CA2325577C Polymer based rapidly dissolving tablets and production processes thereof
09/21/2010CA2299950C Oral adhesive sheet and oral adhesive preparation
09/21/2010CA2251655C In vivo gene transfer methods for wound healing
09/16/2010WO2010105079A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions
09/16/2010WO2010105054A1 Method for modifying the wettability and/or other biocompatibility characteristics of a surface of a biological material by the application of gas cluster ion beam technology and biological materials made thereby
09/16/2010WO2010105042A1 Device for intranasal administration
09/16/2010WO2010105016A1 Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
09/16/2010WO2010104819A2 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery
09/16/2010WO2010104790A2 Fatty-acid based particles
09/16/2010WO2010104786A1 Use of cryogenic processing to obtain a substantially-thickened formulation
09/16/2010WO2010104563A2 Highly compactable and durable direct compression excipients and excipient systems
09/16/2010WO2010104485A2 Valsartan formulations
09/16/2010WO2010104464A1 Oral delivery product
09/16/2010WO2010104175A1 Composition for oral administration
09/16/2010WO2010104170A1 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
09/16/2010WO2010104128A1 Ph-responsive liposome
09/16/2010WO2010104023A1 Infusion solution for administration to peripheral vein comprising carbohydrate solution having vitamin b1 contained therein stably
09/16/2010WO2010103959A1 Ameliorating agent for chronic obstructive pulmonary disease
09/16/2010WO2010103845A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103844A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103514A1 Silica nanocapsules from nano-emulsions obtained by phase inversion
09/16/2010WO2010103505A1 Foamable topical composition
09/16/2010WO2010103473A1 Method of treatment of polycystic diseases and chronic lymphocytic leukemia
09/16/2010WO2010103404A1 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/16/2010WO2010103402A1 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
09/16/2010WO2010103374A2 Oily suspension containing probiotic bacteria for paediatric uses
09/16/2010WO2010103367A1 Pulsatile release composition of therapeutic agent
09/16/2010WO2010103365A2 Sustained release composition of therapeutic agent
09/16/2010WO2010103119A1 Compositions and methods for elimination of gram-negative bacteria
09/16/2010WO2010103118A1 Chemotherapeutic composition for the treatment of cancer
09/16/2010WO2010103116A2 Method of treating eczema
09/16/2010WO2010103045A1 Treatment of diabetes and metabolic syndrome
09/16/2010WO2010103039A1 Immediate release pharmaceutical compositions comprising oxycodone and naloxone
09/16/2010WO2010103022A2 Oil-in-water adjuvanted influenza vaccine
09/16/2010WO2010102991A2 Riluzole liquid emulsions
09/16/2010WO2010102972A1 Plasma-adapted full electrolyte solution
09/16/2010WO2010102923A2 Riluzole aqueous suspensions
09/16/2010WO2010102862A1 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
09/16/2010WO2010102841A1 Compressible tablet material having an oil-containing active substance, tablet as well as method and device for the production thereof
09/16/2010WO2010102770A1 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical application
09/16/2010WO2010102762A1 Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides
09/16/2010WO2010102737A1 Nanonized testosteron formulations for improved bioavailability
09/16/2010WO2010102508A1 Preparation method of carotenoid oil suspensions with low viscosity and high fluidity and its use
09/16/2010WO2010086881A3 Pharmaceutical compositions comprising phosphate-binding polymer
09/16/2010WO2010084397A3 Modified release solid pharmaceutical compositions of trimetazidine and process thereof
09/16/2010WO2010082092A4 Propofol based anesthetic with preservative
09/16/2010WO2010079047A3 Octreotide depot formulation with constantly high exposure levels
09/16/2010WO2010077732A3 Implantable analgesic
09/16/2010WO2010077669A3 Palonosetron formulation
09/16/2010WO2010074711A3 Ceramic honeycomb structure skin coating
09/16/2010WO2010068864A3 Polyesters with grafted zwitterions
09/16/2010WO2010065329A3 Nanoparticles for cancer treatment
09/16/2010WO2010064261A9 Synergistic combinations of aztreonam with the carbapenems meropenem and ertapenem
09/16/2010WO2010059963A3 Preparation and methodology of silk fibroin nanoparticles
09/16/2010WO2010057117A3 Topical transdermal drug delivery compositions
09/16/2010WO2010056847A3 Lyophilization formulation
09/16/2010WO2010042212A3 Methods for treating or preventing pain using spicamycin derivatives
09/16/2010WO2010041268A3 Crosslinked polymers
09/16/2010WO2010029093A3 Compositions for percutaneous administration
09/16/2010WO2010005770A8 Electrostatically charged nasal application multipurpose products and method
09/16/2010WO2009147144A3 Composition comprising an antibiotic and a corticosteroid
09/16/2010WO2009129210A3 Compositions and methods for treating post-operative pain using clonidine and bupivacaine
09/16/2010WO2009106999A3 Hollow nanoparticles and uses thereof
09/16/2010WO2009083225A3 Antibody-containing formulation for the use for treating cardiovascular diseases associated with atherosclerosis
09/16/2010US20100234828 Methods and Compositions for Facilitating Arterial Access
09/16/2010US20100234784 Interpenetrating network of pva hydrogel cool-compression bandage
09/16/2010US20100234462 Topical composition
09/16/2010US20100234337 Foaming compositions for hair care
09/16/2010US20100234305 Polymeric delivery formulations of leuprolide with improved efficacy
09/16/2010US20100233350 Drug delivery composition and methods of making same using nanofabrication
09/16/2010US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A
09/16/2010US20100233278 Rapidly disintegrating solid preparation
09/16/2010US20100233277 Biodegradable polymer scaffold and process for preparation thereof
09/16/2010US20100233276 Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation
09/16/2010US20100233275 Process for preparing lipid nanoparticles
09/16/2010US20100233274 Means and methods for enhancing weight gain in poultry
09/16/2010US20100233273 Polymer compositions with bioactive agent, medical articles, and methods
09/16/2010US20100233272 Dosage forms comprising celecoxib providing both rapid and sustained pain relief
09/16/2010US20100233271 Slow release of organic salts of local anesthetics for pain relief
1 ... 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 ... 2991